ArticleScientific reports2025
Integrative biochemical and computational analysis of leflunomide-induced redox alterations in Nauphoeta cinerea.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Leflunomide (LF) is an immunomodulator classified as a disease-modifying anti-rheumatic agent. Its mechanisms of action include inhibition of dihydroorotate dehydrogenase in lymphocytes, resulting in immunosuppressive effects, and blocking tyrosine kinase activation, generating anti-inflammatory effects. This study aimed to study biochemical parameters 24 h after leflunomide administration to Nauphoeta cinerea (Cockroach) model, focusing on toxicity assessment. Biochemical analyses were performed, and molecular docking studies were conducted with the proteins 6VCD, 2B3X, and 2B3Y. Leflunomide altered biochemical parameters by increasing markers such as PSH, NPSH, TBARS, and iron levels, suggesting that LF may induce oxidative stress. This was supported by a dose-dependent increase in PSH, indicating an adaptive defense response. Furthermore, a significant increase in NPSH was observed at 128 µg/mL coupled with increased lipid peroxidation and elevated iron levels at 256 µg/mL. Additionally, LF exhibited high molecular activity by interacting with the target proteins, presenting major alkyl-type bonds, in addition to the interaction of fluorine with 2 proteins (6VCD and 2B3Y). In conclusion, leflunomide appears to induce oxidative stress in a dose-dependent manner, triggering adaptive defense responses and altering key biochemical markers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.